Skip to main content

Table 5 Clinical short-term outcomes in the two groups

From: Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy

 

NACT (n=52)

Non-NACT (n=271)

P

LOS, d

7.90±1.312

7.71±1.63

0.424

First bowel movement, d

2.92±0.71

3.01±0.99

0.560

Chest tube removal, d

5.37±1.46

5.13±1.29

0.238

Postoperative complications

11 (21.2)

56 (20.7)

0.936

No. of total lymph nodes harvested

23.42±4.25

22.52±4.71

0.198

No. of thoracic lymph nodes harvested

15.46±3.83

14.07±4.52

0.039*

No. of abdominal lymph nodes harvested

7.96±2.73

8.44±3.36

0.331

R0 resection

49 (94.2)

263 (97.0)

0.543

R1 resection

0 (0)

0 (0)

 

R2 resection

3 (5.8)

8 (3.0)

 
  1. LOS length of stay, NACT neoadjuvant chemotherapy
  2. Numbers in parentheses are the percentages
  3. P < 0.05